Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:olopatadine
|
| gptkbp:approvalYear |
1996
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
S01GX09
|
| gptkbp:brand |
gptkb:olopatadine
|
| gptkbp:chemicalClass |
antihistamine
|
| gptkbp:form |
eye drops
|
| https://www.w3.org/2000/01/rdf-schema#label |
Patanol
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
histamine H1 receptor antagonist
mast cell stabilizer |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
headache
blurred vision eye irritation dry eyes |
| gptkbp:usedFor |
allergic conjunctivitis
|
| gptkbp:bfsParent |
gptkb:olopatadine
|
| gptkbp:bfsLayer |
6
|